84
Views
0
CrossRef citations to date
0
Altmetric
Letters

Systemic autoimmunity with Castleman-like lymphadenopathy: a diagnostic and therapeutic challenge

ORCID Icon
Pages 248-249 | Accepted 28 Oct 2021, Published online: 11 Jan 2022

References

  • Saleh M, Hallbeck M, Sjöwall C. A rare case of idiopathic multicentric Castleman disease in a patient with long-standing systemic autoimmunity. Scand J Rheumatol 2021; 2;1–3. Epub ahead of print. doi:https://doi.org/10.1080/03009742.2021.1947591
  • Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 2017;129:1646–57.
  • Kojima M, Motoori T, Nakamura S. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother 2006;60:663–72.
  • Higashi K, Matsuki Y, Hidaka T, Aida S, Suzuki K, Nakamura H. Primary Sjögren’s syndrome associated with hyaline-vascular type of Castleman’s disease and autoimmune idiopathic thrombocytopenia. Scand J Rheumatol 1997;26:482–4.
  • Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 2000;50:304–12.
  • Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, De Somer L, Dooley J, Tousseyn T, et al. ADA2 deficiency mimicking idiopathic multicentric Castleman disease. Pediatrics 2018;142:e20172266.
  • Beaufils C, Fernandez I, Marchitto L, Morin MP, De Bruycker JJ, and Cellot S , et al. Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1/2 inhibition. J Allergy Clin Immunol Pract. 2021 9 (10).
  • Staels F, Betrains A, Woei-A-Jin S, Boeckx N, Beckers M, Bervoets A, et al. Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome. Front Immunol 2021;12:678927.
  • Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood 2018;132:2323–30.
  • De Marchi G, De Vita S, Fabris M, Scott CA, Ferraccioli G. Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica 2004;89:ECR03.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.